{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:39:49Z","timestamp":1784893189277,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ejpb.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T08:22:07Z","timestamp":1305966127000},"page":"241-249","source":"Crossref","is-referenced-by-count":68,"title":["Improved efficacy in the treatment of contact dermatitis in rats by a dermatological nanomedicine containing clobetasol propionate"],"prefix":"10.1016","volume":"79","author":[{"given":"M.C.","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.P.","family":"Rezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Coradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.R.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2011.05.002_b0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2009.07.018","article-title":"Different approaches for improving skin accumulation of topical corticosteroids","volume":"380","author":"Senyigit","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J. Am. Acad. Derm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.tiv.2007.11.022","article-title":"Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model","volume":"22","author":"Z\u00f6ller","year":"2008","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejpb.2011.05.002_b0020","first-page":"2","article-title":"Incremento de la actividad timol\u00edtica del clobetasol em forma liposomal","volume":"38","author":"Cap\u00f3","year":"2004","journal-title":"Rev. Cubana Farm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0025","first-page":"233","article-title":"Clobetasol propionate solid lipid nanoparticles cream for effective treatment if eczema: formulation and clinical implications","volume":"43","author":"Kalariya","year":"2005","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/03639041003598960","article-title":"Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization and in vitro drug release study","volume":"36","author":"Marchiori","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nano.2006.11.008","article-title":"The present and future of nanotechnology in human health care","volume":"3","author":"Sahoo","year":"2007","journal-title":"Nanomedicine: N.B.M."},{"key":"10.1016\/j.ejpb.2011.05.002_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0149-2918(98)80032-5","article-title":"The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses","volume":"20","author":"Gordon","year":"1998","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejpb.2011.05.002_b0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejpb.2007.08.007","article-title":"Bioavailability and bioequivalence of topical glucocorticoids","volume":"68","author":"Wiedersberg","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0050","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11095-008-9800-3","article-title":"Preparation and manufacture of polymeric nanoparticles","volume":"25","author":"Vauthier","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2011.05.002_b0055","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1590\/S0100-40422003000500017","article-title":"Caracteriza\u00e7\u00e3o e estabilidade f\u00edsico-qu\u00edmica de sistemas polim\u00e9ricos nanoparticulados para administra\u00e7\u00e3o de f\u00e1rmacos","volume":"25","author":"Schaffazick","year":"2003","journal-title":"Quim. Nova"},{"key":"10.1016\/j.ejpb.2011.05.002_b0060","first-page":"325","article-title":"Hydrophilic gel containing nanocapsules of diclofenac: development, stability study and physic-chemical characterization","volume":"58","author":"Mil\u00e3o","year":"2003","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2011.05.002_b0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2003.11.029","article-title":"Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate","volume":"272","author":"Jim\u00e9nez","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0070","first-page":"900","article-title":"Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization","volume":"60","author":"Alves","year":"2005","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejpb.2011.05.002_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2007.03.031","article-title":"Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers","volume":"341","author":"Alves","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1166\/jbn.2009.1028","article-title":"Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response","volume":"5","author":"Paese","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/117739280700200002","article-title":"Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications","volume":"2","author":"Guterres","year":"2007","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.ejpb.2011.05.002_b0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","article-title":"Nanoparticles \u2013 an efficient carrier for drug delivery into the hair follicles","volume":"66","author":"Ladermann","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0095","first-page":"459","article-title":"Evaluation of lipossomal clobetasol propionate topical formulation for intra-dermal delivery","volume":"62","author":"Rao","year":"2000","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2011.05.002_b0100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jconrel.2009.11.013","article-title":"Lecithin\/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin","volume":"142","author":"Senyigit","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2011.05.002_b0105","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.jid.5700726","article-title":"Skin contact irritation conditions the development and severity of allergic contact dermatitis","volume":"127","author":"Bonneville","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood.V97.3.587","article-title":"Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes","volume":"97","author":"Di Virgilio","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2011.05.002_b0115","first-page":"301","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dnp.2003.16.3.876886","article-title":"Involvement of purinergic signaling in cardiovascular diseases","volume":"16","author":"Ralevic","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.ejpb.2011.05.002_b0125","doi-asserted-by":"crossref","first-page":"33116","DOI":"10.1074\/jbc.271.51.33116","article-title":"Identification and characterization of CD39 vascular ATP diphosphohydrolase","volume":"271","author":"Kaczmarek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2011.05.002_b0130","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4049\/jimmunol.146.7.2235","article-title":"Expression, distribution and biochemistry of human CD39: role in activation-associated homotypic adhesion of lymphocytes","volume":"146","author":"Kansas","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V106.11.3088.3088","article-title":"CD39\/NTPDase1 variants identified in human neutrophils regulate antithrombotic activity","volume":"106","author":"Olson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2011.05.002_b0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm0402-358","article-title":"CD39 is dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness","volume":"8","author":"Mizumoto","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejpb.2011.05.002_b0145","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1152\/ajpcell.1997.273.3.C973","article-title":"Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5\u2032-nucleotidase in myeloid leukocytes","volume":"273","author":"Clifford","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0150","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","article-title":"B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes","volume":"99","author":"Damle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejpb.2011.05.002_b0275","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1200\/JCO.1998.16.12.3788","article-title":"Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus associated non-Hodgkin\u2019s lymphomas. Burkitt\u2019s lymphoma study group","volume":"16","author":"Davi","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0160","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.4049\/jimmunol.170.6.2962","article-title":"Secretion of IL-2 and IFN-gama, but not IL-4, by antigen-specific T cells requires extracellular","volume":"170","author":"Langston","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/BF03401797","article-title":"CD39 modulates endothelial cell activation and apoptosis","volume":"6","author":"Goepfert","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejpb.2011.05.002_b0170","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1166\/jbn.2009.1030","article-title":"Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: influence of the nanostructured system","volume":"5","author":"Fontana","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0175","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1166\/jnn.2010.1920","article-title":"Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release and photostability","volume":"10","author":"Fontana","year":"2010","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1166\/jbn.2009.1004","volume":"5","author":"J\u00e4ger","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0185","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1590\/S0100-40422007000400032","article-title":"Teixeira Adsor\u00e7\u00e3o de oligonucleot\u00eddeos em nanoemuls\u00f5es obtidas por emulsifica\u00e7\u00e3o espont\u00e2nea","volume":"30","author":"Martini","year":"2007","journal-title":"Quim. Nova"},{"key":"10.1016\/j.ejpb.2011.05.002_b0190","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/chromsci\/48.8.637","article-title":"Development and validation of a fast RP-HPLC method for the determination of clobetasol propionate in topical nanocapsule suspensions","volume":"48","author":"Fontana","year":"2010","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.ejpb.2011.05.002_b0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0014-827X(01)01057-6","article-title":"Rheological characterization of hydroalcoholic gels \u2013 15% ethanol \u2013 of Carbopol Ultrez\u2122 10","volume":"56","author":"Fresno Contreras","year":"2001","journal-title":"Il Farmaco"},{"key":"10.1016\/j.ejpb.2011.05.002_b0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2005.12.001","article-title":"Evaluation of gender difference in skin type and pH","volume":"41","author":"Kim","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejpb.2011.05.002_b0205","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1590\/S1516-93322006000400008","article-title":"Desenvolvimento e avalia\u00e7\u00e3o da estabilidade f\u00edsica de lo\u00e7\u00f5es O\/A contendo filtros solares","volume":"42","author":"Borghetti","year":"2006","journal-title":"Rev. Bras. Cienc. Farm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00081-9","article-title":"Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization","volume":"239","author":"Hu","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00112-0","article-title":"Modeling of drug release from delivery systems based on hydroxypropylk methylcellulose (HPMC)","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2011.05.002_b0220","first-page":"272","article-title":"Controlled release of model substances from pH-sensitive hydrogels","volume":"52","author":"Quintanar-Guerrero","year":"2008","journal-title":"J. Mex. Chem. Soc."},{"key":"10.1016\/j.ejpb.2011.05.002_b0225","first-page":"876","article-title":"Atividade da NTPDase de linf\u00f3citos na dermatite de contato antes e ap\u00f3s tratamento com dexametasona nanoestruturada","volume":"28","author":"Brum","year":"2009","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0230","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood, isolation on mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g, Scand","volume":"97","author":"B\u00f6yum","year":"1968","journal-title":"J. Clin. Lab. Invest. Suppl."},{"key":"10.1016\/j.ejpb.2011.05.002_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbagen.2004.09.006","article-title":"Characterization of NTPDase (NTPDase 1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes","volume":"1721","author":"Leal","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejpb.2011.05.002_b0240","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2011.05.002_b0245","unstructured":"R.P. Chhabra, J.F. Richardson, Non-newtonian Flow and Applied Rheology: Engineering Applications, second ed., 2008, pp. 5\u201312."},{"key":"10.1016\/j.ejpb.2011.05.002_b0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijpharm.2006.09.045","article-title":"Rheological behavior of gel and meloxicam release","volume":"333","author":"Martinez","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2011.05.002_b0255","series-title":"Pharmaceutical Excepients","author":"Rowe","year":"2001"},{"key":"10.1016\/j.ejpb.2011.05.002_b0260","first-page":"84","article-title":"Spreading of semisolid formulations","volume":"26","author":"Garg","year":"2002","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.ejpb.2011.05.002_b0265","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1023\/A:1018997520950","article-title":"Assessment of value and applications of in vitro testing of topical dermatological drug products","volume":"16","author":"Flynn","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2011.05.002_b0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-4889(96)00123-1","article-title":"A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation","volume":"1355","author":"Soslau","year":"1997","journal-title":"Biochim. Biophys. Acta"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111001627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111001627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:00:57Z","timestamp":1686092457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641111001627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0939641111001627"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2011.05.002","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}